Works by Chanan‐Khan, Asher

Results: 121
    1

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

    Published in:
    2018
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Sharma, Mayank;
    • Menghani, Richa;
    • Temkit, M'hamed;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Paulus, Aneel;
    • Aslam, Nabeel;
    • Sher, Taimur;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher;
    • Temkit, M'hamed;
    • Colon-Otero, Gerardo;
    • Chanan-Khan, Asher
    Publication type:
    journal article
    2
    3
    4
    5

    The development of novel targeted therapeutics for treatment of multiple myeloma research roundtable.

    Published in:
    European Journal of Haematology, 2003, v. 70, n. 4, p. 263, doi. 10.1034/j.1600-0609.2003.t01-2-00011.x
    By:
    • Anderson, Kenneth C.;
    • Barlogie, Bart;
    • Berenson, James R.;
    • Dalton, William S.;
    • Adams, Julian;
    • Alsina, Melissa;
    • Bekker, Pirow;
    • Bergsagel, Peter L.;
    • Boise, Lawrence;
    • Chan, Kyle;
    • Chanan-Khan, Asher A.;
    • Comenzo, Raymond;
    • Congdon, Deborah;
    • Croucher, Peter;
    • Epstein, Joshua;
    • Fenton, Robert;
    • Fonseca, Rafael;
    • Gallant, Gilles;
    • Hussein, Mohamad A.;
    • Jagannath, Sundar
    Publication type:
    Article
    6
    7
    8
    9

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    10

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 338, doi. 10.1002/ajh.25385
    By:
    • Fang, Hong;
    • Reichard, Kaaren K.;
    • Rabe, Kari G.;
    • Hanson, Curtis A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Smoley, Stephanie A.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Van Dyke, Daniel L.;
    • Parikh, Sameer A.
    Publication type:
    Article
    11

    Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1362, doi. 10.1002/ajh.24915
    By:
    • Hampel, Paul J.;
    • Chaffee, Kari G.;
    • King, Rebecca L.;
    • Simonetto, Douglas;
    • Larson, Melissa C.;
    • Achenbach, Sara;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Schwager, Susan M.;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    12
    13

    The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
    By:
    • Parikh, Sameer A.;
    • Achenbach, Sara J.;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Chanan‐Khan, Asher A.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Muchtar, Eli;
    • Fonder, Amie L.;
    • McCullough, Kristen B.;
    • Nedved, Adrienne N.;
    • Smith, Matthew D.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Finnes, Heidi D.;
    • Shanafelt, Tait D.
    Publication type:
    Article
    14
    15

    Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 12, p. 2876, doi. 10.1002/cam4.1246
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Temkit, M'hamed;
    • Menghani, Richa;
    • Sharma, Mayank;
    • Meghji, Zahara;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh K.;
    • Paulus, Aneel;
    • Kakar, Tanya S.;
    • Hodge, David O.;
    • Colibaseanu, Dorin T.;
    • Vizzini, Michael R.;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher A.
    Publication type:
    Article
    16
    17
    18

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    19
    20

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    21
    22
    23

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0237-1
    By:
    • Kumar, Vivek;
    • Ailawadhi, Sikander;
    • Bojanini, Leyla;
    • Mehta, Aditya;
    • Biswas, Suman;
    • Sher, Taimur;
    • Roy, Vivek;
    • Vishnu, Prakash;
    • Marin-Acevedo, Julian;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Aulakh, Sonikpreet;
    • Iqbal, Madiha;
    • Manochakian, Rami;
    • Tan, Winston;
    • Chanan-Khan, Asher;
    • Ailawadhi, Meghna
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 7, p. 1096, doi. 10.1080/10428190902912460
    By:
    • Chanan-Khan, Asher;
    • Miller, Kena C.;
    • Musial, Laurie;
    • Padmanabhan, Swaminathan;
    • Yu, Jihnhee;
    • Ailawadhi, Sikander;
    • Sher, Taimur;
    • Mohr, Alice;
    • Bernstein, Zale P.;
    • Barcos, Maurice;
    • Patel, Mehul;
    • Iancu, Dan;
    • Lee, Kelvin;
    • Czuczman, Myron S.
    Publication type:
    Article
    30

    The many lives of thalidomide.

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 6, p. 861, doi. 10.1080/10428190902964784
    By:
    • Patel, Mehul P.;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Arterial thrombosis in four patients treated with thalidomide.

    Published in:
    Leukemia & Lymphoma, 2005, v. 46, n. 2, p. 239, doi. 10.1080/10428190400015675
    By:
    • Scarpace, Sarah L.;
    • Hahn, Theresa;
    • Roy, Hilary;
    • Brown, Karen;
    • Paplham, Pamela;
    • Chanan-Khan, Asher;
    • van Besien, Koen;
    • McCarthy, Jr, Philip L.
    Publication type:
    Article
    37
    38
    39
    40

    Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 13, p. 3188, doi. 10.1080/10428194.2020.1795159
    By:
    • Fraser, Graeme A.M.;
    • Chanan-Khan, Asher;
    • Demirkan, Fatih;
    • Santucci Silva, Rodrigo;
    • Grosicki, Sebastian;
    • Janssens, Ann;
    • Mayer, Jiri;
    • Bartlett, Nancy L.;
    • Dilhuydy, Marie-Sarah;
    • Loscertales, Javier;
    • Avigdor, Abraham;
    • Rule, Simon;
    • Samoilova, Olga;
    • Pavlovsky, Miguel A.;
    • Goy, Andre;
    • Mato, Anthony;
    • Hallek, Michael;
    • Salman, Mariya;
    • Tamegnon, Monelle;
    • Sun, Steven
    Publication type:
    Article
    41
    42

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    43

    Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2075, doi. 10.1080/10428194.2017.1416364
    By:
    • Cramer, Paula;
    • Traina, Shana;
    • Chan, Eric K. H.;
    • Mahler, Michelle;
    • Salman, Mariya;
    • Diels, Joris;
    • Sengupta, Nishan;
    • Howes, Angela;
    • Chanan-Khan, Asher;
    • Fraser, Graeme;
    • Santucci-Silva, Rodrigo;
    • Grosicki, Sebastian;
    • Dilhuydy, Marie-Sarah;
    • Janssens, Ann;
    • Loscertales, Javier;
    • Rule, Simon;
    • Goy, Andre
    Publication type:
    Article
    44

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1630, doi. 10.1080/10428194.2016.1257795
    By:
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.;
    • Noseworthy, Peter A.;
    • Goede, Valentin;
    • Chaffee, Kari G.;
    • Bahlo, Jasmin;
    • Call, Timothy G.;
    • Schwager, Susan M.;
    • Ding, Wei;
    • Eichhorst, Barbara;
    • Fischer, Kirsten;
    • Leis, Jose F.;
    • Chanan-Khan, Asher Alban;
    • Hallek, Michael;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    45

    Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 6, p. 1376, doi. 10.1080/10428194.2016.1251592
    By:
    • Finnes, Heidi D.;
    • Chaffee, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Bowen, Deborah A.;
    • Conte, Michael;
    • McCullough, Kristen B.;
    • Merten, Julianna A.;
    • Bartoo, Gabriel T.;
    • Smith, Matthew D.;
    • Leis, Jose;
    • Chanan-Khan, Asher;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    46

    Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 6, p. 1291, doi. 10.3109/10428194.2015.1128540
    By:
    • Wendtner, Clemens M.;
    • Hallek, Michael;
    • Fraser, Graeme A. M.;
    • Michallet, Anne-Sophie;
    • Hillmen, Peter;
    • Dürig, Jan;
    • Kalaycio, Matt;
    • Gribben, John G.;
    • Stilgenbauer, Stephan;
    • Buhler, Andreas;
    • Kipps, Thomas J.;
    • Purse, Brendan;
    • Zhang, Jennie;
    • De Bedout, Sabine;
    • Mei, Jay;
    • Chanan-Khan, Asher
    Publication type:
    Article
    47

    Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 12, p. 3320, doi. 10.3109/10428194.2015.1030641
    By:
    • Niesvizky, Ruben;
    • Badros, Ashraf Z.;
    • Costa, Luciano J.;
    • Ely, Scott A.;
    • Singhal, Seema B.;
    • Stadtmauer, Edward A.;
    • Haideri, Nisreen A.;
    • Yacoub, Abdulraheem;
    • Hess, Georg;
    • Lentzsch, Suzanne;
    • Spicka, Ivan;
    • Chanan-Khan, Asher A.;
    • Raab, Marc S.;
    • Tarantolo, Stefano;
    • Vij, Ravi;
    • Zonder, Jeffrey A.;
    • Huang, Xiangao;
    • Jayabalan, David;
    • Di Liberto, Maurizio;
    • Huang, Xin
    Publication type:
    Article
    48
    49

    Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 2, p. 387, doi. 10.3109/10428194.2012.713481
    By:
    • Chitta, Kasyapa S.;
    • Paulus, Aneel;
    • Ailawadhi, Sikander;
    • Foster, Barbara A.;
    • Moser, Michael T.;
    • Starostik, Petr;
    • Masood, Aisha;
    • Sher, Taimur;
    • Miller, Kena C.;
    • Iancu, Dan M.;
    • Conroy, Jeffrey;
    • Nowak, Norma J.;
    • Sait, Sheila N.;
    • Personett, David A.;
    • Coleman, Morton;
    • Furman, Richard R.;
    • Martin, Peter;
    • Ansell, Stephen M.;
    • Lee, Kelvin;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    50